Kris Famm

It will really help us hone the intervention, this is almost the epicenter of convergence because the technology is not only helping you to monitor a disease but it is also actually the therapy.

We have had really promising results in animal tests, where we've shown we can address some chronic diseases with this mechanism, and now we are bringing that work into the clinic, our goal is to have our first medicines ready for regulatory approval in seven years.